APAF-1 is related to an undifferentiated state in the testicular germ cell tumor pathway

Cancer Science

Volumn 102, Issue 1, 2011, Pages 267-274

  Behjati, Reza ^a   Kawai, Koji ^a   Inadome, Yukinori ^b   Kano, Junko ^a   Akaza, Hideyuki ^a   Noguchi, Masayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Hitachi   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CYTOKERATIN 16; KI 67 ANTIGEN; TRANSCRIPTION FACTOR GATA 4; VIMENTIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ECTODERM; EMBRYONAL CARCINOMA; ENDODERM; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESODERM; MIXED TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SEMINOMA; TERATOMA; TUMOR DIFFERENTIATION; TUMOR GROWTH; YOLK SAC TUMOR;

ADOLESCENT; ADULT; AGED; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CHILD; CHILD, PRESCHOOL; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; OCTAMER TRANSCRIPTION FACTOR-3; TESTICULAR NEOPLASMS;

EID: 78650216631     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01750.x     Document Type: Article

References (29)

1. van de Geijn GJ, Hersmus R, Looijenga LH. Recent developments in testicular germ cell tumor research. Birth Defects Res C Embryo Today 2009; 87(1): 96-113.
2. Walschaerts M, Huyghe E, Muller A, Bachaud JM, Bujan L, Thonneau P. Doubling of testicular cancer incidence rate over the last 20 years in southern France. Cancer Causes Control 2008; 19(2): 155-61.
3. Clemmesen J. A doubling of morbidity from testis carcinoma in Copenhagen, 1943-1962. Acta Pathol Microbiol Scand 1968; 72(2): 348-9.
4. Bergström R, Adami HO, Möhner M et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 1996; 88: 727-33.
5. Richiardi L, Bellocco R, Adami HO et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 2004; 13: 2157-66.
6. Kawai K, Hinotsu S, Oikawa T et al. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor. Jpn J Clin Oncol 2006; 36(11): 723-30.
7. Nakata S, Takahashi H, Ohtake N et al. Chronological and regional differences of testicular cancer - epidemiological analysis of incidence in Gunma prefecture and estimated data of national survey, and of death in Japan. Nippon Hinyokika Gakkai Zasshi 2002; 93(1): 1-6.
8. Thomas M, Ulbright MD, Mahul B, Amin MD, Robert H, Young MD. Tumors of the Testis, Adenex, Spermatic Cord, and Scrotom, 3rd edn. Washington DC: AFIP (Armed Forces Institute of pathology) 1999; 41-55 (Atlas of tumor pathology; vol 25).
9. Damjanov I, Solter D. Experimental teratoma. Curr Top Pathol 1974; 59: 69-130.
10. Pierce GB, Dixon FJ Jr. Testicular teratomas. I. Demonstration of teratogenesis by metamorphosis of multipotential cells. Cancer 1959; 12(3): 573-83.
11. Kleinsmith LJ, Pierce GB Jr. Multipotentiality of single embryonal carcinoma cells. Cancer Res 1964; 24: 1544-51.
12. Pierce GB, Verney EL. An in vitro and in vivo study of differentiation in teratocarcinomas. Cancer 1961; 14: 1017-29.
13. Lind GE, Skotheim RI, Lothe RA. The epigenome of testicular germ cell tumors. APMIS 2007; 115(10): 1147-60.
14. Reubinoff BE, Pera MF, Fong CY et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000; 18(4): 399-404.
15. Twiddy D, Brown DG, Adrain C et al. Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex. J Biol Chem 2004; 279(19): 19665-82.
16. Lindholm D, Arumäe U. Cell differentiation: reciprocal regulation of Apaf-1 and the inhibitor of apoptosis proteins. J Cell Biol 2004; 167(2): 193-5.
17. Fadeel B, Ottosson A, Pervaiz S. Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance. Cell Death Differ 2008; 15(3): 443-52.
18. Niedojadło K, Łabedzka K, Łada E et al. Apaf-1 expression in human cutaneous melanoma progression and in pigmented nevi. Pigment Cell Res 2006; 19(1): 43-50.
19. Zlobec I, Vuong T, Compton CC. The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative, high-dose-rate brachytherapy. Cancer 2006; 106(2): 284-6.
20. Christoph F, Kempkensteffen C, Weikert S et al. Frequent epigenetic inactivation of p53 target genes in seminomatous and nonseminomatous germ cell tumors. Cancer Lett 2007; 247(1): 137-42.
21. Bala S, Oliver H, Renault B. Genetic analysis of the APAF1 gene in male germ cell tumors. Genes Chromosomes Cancer 2000; 28(3): 258-68.
22. Honarpour N, Du C, Richardson JA. Adult Apaf-1-deficient mice exhibit male infertility. Dev Biol 2000; 218(2): 248-58.
23. Wright KM, Linhoff MW, Potts PR, Deshmukh M. Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis. J Cell Biol 2004; 167(2): 303-13.
24. Nouri MS, Komatsu S. Comparative analysis of soybean plasma membrane proteins under osmotic stress using gel-based and LC MS/MS-based proteomics approaches. Proteomics 2010; 10(10): 1930-45.
25. Ho CK, Bush JA, Li G. Tissue-specific regulation of Apaf-1 expression by p53. Oncol Rep 2003; 10(5): 1139-43.
26. Peng HQ, Hogg D, Malkin D et al. Mutations of the p53 gene do not occur in testis cancer. Cancer Res 1993; 53(15): 3574-8.
27. Schenkman NS, Sesterhenn IA, Washington L et al. Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors. J Urol 1995; 154 (2 Pt 1): 617-21.
28. Takayama H, Takakuwa T, Tsujimoto Y et al. Frequent Fas gene mutations in testicular germ cell tumors. Am J Pathol 2002; 161(2): 635-41.
29. Chen L, Li X, Wang GL, Wang Y, Zhu YY, Zhu J. Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma. Tumori 2008; 94(4): 531-8.